HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Clusterin deficiency in eyes with pseudoexfoliation syndrome may be implicated in the aggregation and deposition of pseudoexfoliative material.

AbstractPURPOSE:
To determine the role of the extracellular chaperone clusterin in the pathophysiology of pseudoexfoliation (PEX) syndrome/glaucoma, which is characterized by the stable deposition of abnormal extracellular fibrillar material in anterior segment tissues.
METHODS:
Real-time PCR, in situ hybridization, and immunohistochemistry were applied to analyze the mRNA and protein expression of clusterin in PEX eyes of patients without and with glaucoma and to compare them with eyes of patients with primary open-angle glaucoma and angle-closure glaucoma and with normal control eyes. Aqueous levels of clusterin were determined by Western blot analysis. Real-time PCR and Western blot analysis were used to study the effect of TGF-beta1, which is significantly increased in the aqueous humor of PEX eyes, on clusterin expression by nonpigmented ciliary epithelial cells in vitro.
RESULTS:
Clusterin mRNA was ubiquitously expressed in most ocular cells and tissues, particularly in the epithelium of ciliary processes, whereas the protein was mostly located to extracellular structures, such as ocular basement membranes and stromal fibers. Real-time PCR and in situ hybridization displayed significant downregulation of clusterin mRNA in all anterior segment tissues of PEX eyes, irrespective of the presence or type of glaucoma, compared with normal and glaucomatous control eyes, whereas posterior segment tissues did not show any differential expression. A generally decreased immunoreactivity, but a prominent binding of clusterin to all PEX deposits, could be observed in ocular tissues of PEX eyes. Clusterin levels in aqueous humor were significantly reduced in eyes of patients with PEX syndrome compared with normal and glaucomatous control eyes. The expression of clusterin mRNA and protein in nonpigmented ciliary epithelial cells was significantly downregulated by TGF-beta1 in vitro.
CONCLUSIONS:
Considering the known role of clusterin as a highly efficient extracellular chaperone, its deficiency in the anterior segment of PEX eyes may promote the stress-induced aggregation and stable deposition of the pathologic extracellular matrix product characteristic of PEX syndrome.
AuthorsMatthias Zenkel, Friedrich E Kruse, Anselm G Jünemann, Gottfried O H Naumann, Ursula Schlötzer-Schrehardt
JournalInvestigative ophthalmology & visual science (Invest Ophthalmol Vis Sci) Vol. 47 Issue 5 Pg. 1982-90 (May 2006) ISSN: 0146-0404 [Print] United States
PMID16639006 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • CLU protein, human
  • Clusterin
  • RNA, Messenger
  • TGFB1 protein, human
  • Transforming Growth Factor beta
  • Transforming Growth Factor beta1
Topics
  • Aged
  • Aged, 80 and over
  • Anterior Eye Segment (metabolism)
  • Blotting, Western
  • Cell Culture Techniques
  • Ciliary Body (drug effects, metabolism, pathology)
  • Clusterin (deficiency, genetics, metabolism)
  • Down-Regulation
  • Epithelium (drug effects, metabolism)
  • Exfoliation Syndrome (complications, metabolism)
  • Extracellular Matrix (metabolism)
  • Female
  • Fluorescent Antibody Technique, Indirect
  • Glaucoma, Angle-Closure (complications, metabolism)
  • Glaucoma, Open-Angle (complications, metabolism)
  • Humans
  • In Situ Hybridization
  • Male
  • Pigment Epithelium of Eye (drug effects, metabolism)
  • RNA, Messenger (metabolism)
  • Reverse Transcriptase Polymerase Chain Reaction
  • Transforming Growth Factor beta (pharmacology)
  • Transforming Growth Factor beta1

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: